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Abstract Hydroxyapatite (HA), fluor-hydroxyapatite
(FHA) with varying levels of fluoride ion substitution and
fluorapatite (FA) were synthesised by the sol–gel method as
possible implant coating or bone-grafting materials. Cal-
cium nitrate and triethyl phosphite were used as precursors
under an ethanol–water based solution. Different amounts of
ammonium fluoride were incorporated for the preparation of
the FHA and FA sol–gels. After heating and powdering the
sol–gels, dissolution behaviour was assessed using ion
chromatography to measure Ca2? and PO4
3- ion release.
Biological behaviour was assessed using cellular prolifera-
tion with human osteosarcoma cells and alamarBlueTM
assay. Statistical analysis was performed with a two way
analysis of variance and post hoc testing with a Bonferroni
correction. Increasing fluoride substitution into an apatite
structure decreased the dissolution rate. Increasing the firing
temperature of the HA, FHA and FA sol–gels up to 1,000 C
decreased the dissolution rate. There was significantly
higher cellular proliferation on highly substituted FHA and
FA than on HA or Titanium. The properties of an implant
coating or bone grafting material can be tailored to meet
specific requirements by altering the amount of fluoride that
is incorporated into the original apatite structure. The dis-
solution behaviour can further be altered by the temperature
at which the sol–gel is fired.
1 Introduction
Hydroxyapatite [HA, Ca10(PO4)6(OH)2] has attracted much
attention for use in combination with Ti and its alloys, the
aim being to combine bioactivity with mechanical strength
[1–3]. Fluorapatite [FA, Ca10(PO4)6F2] has also gained
much interest as pure form; FA is known to have a greater
chemical stability and hence lower bioresorption rate than
HA [4, 5]. There is potential that as HA forms fluor-
hydroxyapatite [FHA, Ca10(PO4)6(OHxFy)] by selective
substitution of OH- with F- it may be possible to alter the
dissolution properties and biological properties of the
material [5].
Previous studies have suggested that fluorapatite
(Ca10(PO4)6F2) has a similar biocompatibility with HA in
terms of its fixation to [1] bone and bone in-growth [6–10].
These studies used discs doped with various amounts of
fluoride ion (F-) to investigate the effect of F- content on
osteoblastic cell behaviour. They concluded that FHA is
biocompatible and that the amount of F- affects cell
attachment, proliferation, morphology and differentiation
of osteoblastic cells, proposing this to be related directly to
the release of the fluoride ions.
C. J. Tredwin
Plymouth University Peninsula Schools of Medicine and
Dentistry, University of Plymouth, The John Bull Building,
Tamar Science Park, Research Way, Plymouth PL6 8BU, UK
A. M. Young  E. A. Abou Neel  G. Georgiou 
J. C. Knowles (&)
Division of Biomaterials and Tissue Engineering, UCL Eastman
Dental Institute, 256 Grays Inn Road, London WC1X 8LD, UK
e-mail: j.knowles@ucl.ac.uk
E. A. Abou Neel
Division of Biomaterials, Conservative Dental Sciences
Department, King Abdulaziz University, Jeddah, Saudi Arabia
E. A. Abou Neel
Biomaterials Department, Faculty of Dentistry, Tanta
University, Tanta, Egypt
J. C. Knowles
WCU Research Centre of Nanobiomedical Science, Dankook
University, San#29, Anseo-dong, Dongnam-gu, Cheonan-si,
Chungnam 330-714, South Korea
123
J Mater Sci: Mater Med (2014) 25:47–53
DOI 10.1007/s10856-013-5050-y
Use of the sol–gel technique is technically simple, cost
effective and beneficial for coating complex shapes such as
implants [11, 12] and our previous study [13] has shown that
it is possible to fabricate HA, FHA and FA effectively using
the sol–gel technique, furthermore this study showed that
levels of fluoride ion substitution in the FHA structure can be
precisely controlled. This study sought to investigate the
potential biological properties of these novel FHA materials
and compare their dissolution and biological behaviour.
2 Materials and methods
2.1 Preparation of HA sols
16.16 g of triethylphosphite (TEP [P(C2H50)3], Aldrich,
USA) was hydrolysed for 72 h in a mixture of 33.12 g of
ethanol and 5.04 g of distilled water (P containing solution,
VWR, UK). This mixture was then added to a solution of
39.36 g calcium nitrate [Ca(NO3)2.4H20, Aldrich USA] in
15.12 g of distilled water. 25 ml of a 5 % w/v solution of
ammonium hydroxide (NH4OH, VWR, UK) was added to
the solution in order to improve gelation and subsequent
formation of an apatite structure; the solution was allowed
to react for 24 h and then aged for a further 24 h at room
temperature.
2.2 Preparation of FHA and FA sols
The FHA sols were prepared using various amounts of
ammonium fluoride (NH4F, Aldrich, USA) in the P con-
taining solution. The [P]/[F] molar ratios were 12, 6, 4 and
3 in order to have the corresponding compositions of
Ca10(PO4)6F0.5OH1.5, Ca10(PO4)6F1OH1, Ca10(PO4)6-
F1.5OH0.5 and Ca10(PO4)6F2 (denoted by replacing the OH
group with F ions in molar ratios of 0.25, 0.5, 0.75 and 1
respectively). After stirring for 72 h, the solutions were
added slowly to a solution containing a stoichiometric
amount (Ca/P * 1.67) of calcium nitrate [Ca(NO3)2.4H20,
Aldrich USA] following the protocol developed for the HA
sols. 25 ml of a 5 % (wt/vol) solution of ammonium
hydroxide (NH4OH, VWR, UK) was added to the solution
in order to improve gelation and subsequent formation of
an apatite structure.
2.3 Dissolution properties
Samples of the Ca10(PO4)6(OH)2, Ca10(PO4)6F0.5OH1.5,
Ca10(PO4)6F1OH1 Ca10(PO4)6F1.5OH0.5 and Ca10(PO4)6F2
sol–gels were heated in air to 600 C for 2 h in a furnace
(Lenton Furnace, Lenton Thermal Designs Limited, UK)
with a ramp of 5 C per minute, dwell time of 60 min and
cool down rate of 10 C per minute. To investigate the
effect of heating Ca10(PO4)6(OH)2, Ca10(PO4)6F1OH1 and
Ca10(PO4)6F2 sol–gels were heated to 600, 700, 800 and
1,000 C using the same protocol. All powders obtained
were subsequently ball milled and passed through a sieve
to give a particle size of approximately 20 lm.
1.0 g of the ball milled samples was placed in a Specac
pressing die set and pressed to 7 tons, and heated in air to
600 C for 2 h in a furnace (Lenton). The 5 mm diameter
solid samples were then placed in 100 ml of ultra-pure
water in a sealed container, 10 ml of this was analysed
using ion chromatography daily for the first 7 days and
then at weekly intervals for a further 6 weeks for Ca 2?
[Dionex ICS–1000 (Dionex Ltd, Surrey, UK)] and PO4
3-
[Dionex ICS–2500 Ion Chromatograpy system (Dionex
Lts, Surrey, UK)] ion release. To ensure that there was no
dilution effect there were 14 identical samples prepared for
each run. All samples were analysed in triplicate and a
mean and standard deviation was calculated. A Chrome-
leon software package was used for data analysis.
2.4 Biological properties
Samples of the Ca10(PO4)6(OH)2, Ca10(PO4)6F0.5OH1.5,
Ca10(PO4)6F1OH1 Ca10(PO4)6F1.5OH0.5 and Ca10(PO4)6F2
sol–gels were heated in air to 600 C for 2 h in a furnace
(Lenton Furnace, Lenton Thermal Designs Limited, UK)
with a ramp of 5 C per minute, dwell time of 60 min and
cool down rate of 10 C per minute. They were subse-
quently ball milled to a particle size of approximately
20 lm. To allow an appropriate flat surface for cell growth
and analysis 0.5 g of the ball milled samples was subse-
quently placed in a Specac die (13 mm wide) and pressed
to 4 tons, and heated in air to 600 C for 2 h in a furnace
(Lenton). The samples were made in triplicate for each
powder type and polished to a 3 lm finish. Polished tita-
nium discs were used as a control. All samples were ster-
ilised at 200 C in a hot air oven (Gallenkamp, Weiss, UK)
for 3 h prior to commencement of the cellular work.
The sterilised samples were pre-treated by incubation in
a growth medium [Dulbecco’s modified Eagles Medium
(DMEM, Gibco), 10 % fetal calf serum, and 1 % penicillin
and streptomycin solution (Gibco)] for 24 h at 37 C
humidified atmosphere incubator of 5 % CO2 in air.
Human Osteosarcoma (HOS) cells were obtained from
the UCL Eastman Dental Institute archive. These cells
were in cryogenic storage and had been previously
obtained from a gingival tissue mucosal biopsy culture
after obtaining ethical approval. These cells were used to
obtain a preliminary estimate of biological compatibility of
Ca10(PO4)6(OH)2, Ca10(PO4)6F0.5OH1.5, Ca10(PO4)6F1OH1
Ca10(PO4)6F1.5OH0.5 and Ca10(PO4)6F2 and to compare it
with both Titanium discs and tissue culture plastic (TCP) as
a positive control. The cells were seeded at a density of
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5 9 103 cells/disc and were cultured at 37 C humidified
atmosphere incubator of 5 % CO2 in air; in a growth
medium. The medium was changed every 3 days.
The measurement of HOS proliferation was based on
measuring the metabolic activity of these cells using ala-
marBlueTM assay. At 1, 3, and 7 days’ time point, the
culture media was removed and the samples were washed
three times with warm PBS. Five hundred microlitres of
10 % Alamar BlueTM in warm Hanks Balanced Salt
Solution was then added to each well and incubated for
90 min. The fluorescence was then measured at 530 nm
excitation, and 590 nm emission using a Fluroskan Ascent
plate reader (Labsystems, Helsinki, Finland). The fluores-
cence measurement was repeated twice for each sample. A
background fluorescence reading was also taken from 10 %
Alamar BlueTM at each occasion.
In summary two readings were taken from each of the
three samples in each group—giving a total of six readings
per group. At the same time two fluorescence readings were
taken from the wells containing only Alamar BlueTM, these
values were then subtracted from the sample readings to give
a true value of fluorescence from the samples and thus cell
proliferation that had occurred. The data was tabulated in
Microsoft Excel Worksheet. Statistical package for social
sciences (SPSS) Version 14 was used to analyze the data. A
two way analysis of variance was undertaken. Initially the
effect of the independent variables to fluorescence was
determined both individually and in combination. This was
followed by a post hoc multiple comparison tests using the
Bonferroni correction. These were used to compare differ-
ences in fluorescence for the different materials at each time
point i.e. if there was a difference in cellular proliferation on
any of the materials at that time point.
Assessment of HOS cell attachment was conducted at
the 7 day time point using scanning electron microscopy
(SEM). Samples for SEM were overnight fixed with 3 %
glutaraldehyde in 0.1 M sodium cacodylate buffer (Agar
Scientific Ltd., Essex, UK) at 4 C, then dehydrated in
graded alcohol (20, 50, 70, 90, and 100 %). The dehydrated
samples were critically dried in hexamethyldisilazane
(HMDS, Taab Laboratories Ltd., Berkshire, UK) for 5 min,
and then left to air dry. The dried samples were then
mounted on aluminium stub; sputter coated with gold–
palladium alloy, and viewed using JEOL 5410LV Scanning
electron microscope (JEOL UK Ltd, UK).
3 Results
3.1 Ion release
The data obtained for the Ca 2? and PO4
3- ion release is
shown graphically in Figs. 1 and 2.
The data obtained for the Ca2? ion release for the
Ca10(PO4)6(OH)2, Ca10(PO4)6F1OH1 and Ca10(PO4)6F2
sol–gel heated to 600, 700, 800 and 1,000 C is shown
graphically in Fig. 3a, b, c, d, e and f. For the calcium
release as a function of fluoride substitution, as can clearly
be seen (Fig. 1), with increasing F- substitution, there is a
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Fig. 1 Calcium (Ca 2?) ion release from sol–gels heated to 600 C,
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Fig. 2 Phosphate (PO4
3-) ion release from sol–gels heated to
600 oC, mean ± standard deviation
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decrease in the amount of Ca2? released. All curves show
an initial faster release of calcium over the first 7 days and
this then plateaus until the end of the experiment. This
same trend is also seen for the PO4
3- release (Fig. 2).
Figure 3a shows the effect of thermal treatment tempera-
ture of Ca10(PO4)6(OH)2 on calcium ion release. As
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Fig. 3 a Graph to show mean (±SD) Ca 2? ion release for the
Ca10(PO4)6(OH)2 produced sol–gel heated to 600, 700, 800 and
1,000 C. b Graph to show mean (±SD) Ca 2? ion release for the
Ca10(PO4)6F1OH1 produced sol–gel heated to 600, 700, 800 and
1,000 C. c Graph to show mean (±SD) Ca 2? ion release for the
Ca10(PO4)6F2 produced sol–gel heated to 600, 700, 800 and 1,000
C.
d Graph to show mean (±SD) PO4
3- ion release for the
Ca10(PO4)6(OH)2 produced sol–gel heated to at 600, 700, 800 and
1,000 C. e Graph to show mean (±SD) PO4
3- ion release for the
Ca10(PO4)6F1OH1 produced sol–gel heated to at 600, 700, 800 and
1,000 C. f Graph to show mean (±SD) PO4
3- ion release for the
Ca10(PO4)6F2 produced sol–gel heated to at 600, 700, 800 and
1,000 oC
50 J Mater Sci: Mater Med (2014) 25:47–53
123
expected, with increasing annealing temperature there is a
decrease in the amount of calcium released. The samples
also show the same initial faster release over the first
7 days. This same trend is seen in the PO4
3- release for this
sample (Fig. 3d) and also for the other compositions
(Fig. 3b,c, e and f).
3.2 Biological behaviour
This data is represented graphically in Fig. 4 and there is
clear trend for increased metabolic activity with increasing
fluoride content, this was only actually significantly differ-
ent with the highest concentrations of fluoride substitution
but at this concentration it was statistically significantly
different to all materials at all time points at P = 0.001.
Ca10(PO4)6F2 showed significantly higher metabolic activ-
ity than HA at 1, 3 and 7 days, Ca10(PO4)6F1.5OH0.5 had
significant higher cellular proliferation on days 1 and 7.
All cell numbers increased between day 1 and 7 indi-
cating that the cells were able to increase their metabolic
activity on all surfaces in the experimental protocol. The
data showed trends in the metabolic activity with the dif-
ferent materials used. At each of the periods tested (1, 3
and 7 days) the metabolic activity values were significantly
high for Ca10(PO4)6F2 (pure fluorapatite). Furthermore
there was a general trend that can be seen very clearly in
the graph in Fig. 4 that the higher the fluoride substitution
that occurred in the apatite structure the higher the meta-
bolic activity.
The statistically significant differences are denoted on
Fig. 4. It is clear from this graph that Ca10(PO4)6F2 is
statistically significantly different from all groups, includ-
ing the control groups at all times points at P \ 0.001.
4 Discussion
4.1 Dissolution behaviour
One of the most important issues when considering
hydroxyapatite (HA) for biological coatings is the disso-
lution rate in an environment where human body fluids
exist. It has been reported that plasma-sprayed HA coatings
dissolve and degrade quickly, resulting in the weakening of
the coating-substrate bonding or the implant fixation to the
host tissues [11, 14, 15]. For this reason any changes to the
HA that result in a higher chemical stability would be an
advantage [16].
The ion release experimental methodology adopted,
allows a possible insight to be gained of how the discs
obtained may behave in vivo. Ca2? and PO4
3- ion release
were chosen to observe the dissolution behaviour of each
disc since the apatite structure is known to collapse by the
release of these ions.
Fig. 4 Bar graph to show mean
(±SD) proliferation of Human
Osteosarcoma Cells over a
7 day period. Statistical analysis
key:*statistically significantly
different from
Ca10(PO4)6F0.5OH1.5 at that
time point. ?statistically
significantly different from
Ca10(PO4)6F1OH1 at that time
point. xstatistically significantly
different from
Ca10(PO4)6F1.5OH0.5 at that
time point. #statistically
significantly different from
Ca10(PO4)6F2 at that time point.
@statistically significantly
different from Ca10(PO4)6OH2
at that time point
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For all the sol–gel prepared discs there was a clear
pattern to the dissolution behaviour and release of Ca2?
and PO4
3- ions. The dissolution of all the discs showed an
initial rapid increase over the first 7 days; this then stabi-
lised to similar level for the next 7 weeks. Importantly, the
fluoride substitution decreased the dissolution of the Ca2?
and PO4
3- ions, that is with the dissolution rate in the order
Ca10(PO4)6(OH)2 [ Ca10(PO4)6F0.5OH1.5 [ Ca10(PO4)6F1
OH1 [ Ca10(PO4)6F1.5OH0.5 [ Ca10(PO4)6F2.
Such a decrease in the dissolution rate of an apatite
driven by the fluoride substitution can be potentially
explained by the structural stability of each prepared disc.
When considering the improvement in the crystallinity and
crystallite size of the fluoride substituted discs [13, 16],
such a retarded dissolution can be partially affected by the
improvement in crystallisation. As a result of the obser-
vations it is deduced that the fluoride substitution effec-
tively controls the dissolution rate of an apatite disc and
suggest the possibility of tailoring the solubility of any
coatings made from the sol–gels through fluoride ion
substitution.
The dissolution behaviour and resultant Ca2? and PO4
3-
Ion release with different heating temperatures showed a
similar profile for all the samples (albeit with different final
values). There was a rapid increase in release of the PO4
3-
ions over the first 7 days, this then stabilised to a similar
level for the next 7 weeks. Importantly, the heating tem-
perature was able to decrease the dissolution of the Ca2?
and PO4
3- ions with all the samples obtained, that is
with the dissolution rate in the order 600 C [
700 C [ 800 C [ 1000 C.
Such a decrease in the dissolution rate of an apatite
driven by the temperature to which the apatite has been
heated can again be explained by the structural stability of
each disc. Increasing the heating temperature from 600 to
1000 C improves the crystallinity and decreases the
crystal size of the HA/FHA/FA discs, suggesting that a
retarded dissolution can be partially affected by the
improvement in crystallisation. As a result of the obser-
vations it can be deduced that heating of the apatite
structure from 600 to 1000 C is effectively able to control
the dissolution rate of an apatite disc and suggest the
possibility of tailoring the solubility of any coatings made
from the sol–gels through controlled heating.
4.2 Cell proliferation
In this study it has been assumed that metabolic activity is
indicative of changes in cellular growth numbers, with an
increasing activity indicating cellular proliferation. The
data shows that there was a clear trend for the fluor-
hydroxyapatite and fluorapatite to outperform the
hydroxyapatite coatings in terms of cellular proliferation.
Considering the known clinical biocompatibility of
titanium and hydroxyapatite, the results of this study
are very encouraging indeed. The hydroxyapatite
[Ca10(PO4)6(OH)2] had significantly lower cellular prolif-
eration on day 1 when compared with titanium, while on
day 3 and 7 there was no significant difference. In contrast
the cellular proliferation results for higher levels of sub-
stitution of the fluoride coating were significantly better
than both titanium and hydroxyapatite. Postulating this
forward to the clinical situation suggests that cellular pro-
liferation and hence the first stages of healing could
potentially be faster with fluoride substituted apatite coat-
ings than with hydroxyapatite coatings or titanium itself.
Further encouragement from these results is that the
higher level of fluoride substitution coatings performed
significantly better than the tissue culture plastic. It must be
understood that TCP is specifically designed to support and
encourage cellular growth; for the Ca10(PO4)6F2 and
Ca10(PO4)6F1.5OH0.5 to significantly outperform this shows
great potential for use in vivo as a highly compatible
material.
The results of this study provide support and build on
the current knowledge in the literature. Fluorapatite coat-
ings have attracted a great deal of attention in areas
requiring long-term chemical and mechanical stability [17–
19]. Previous studies have suggested that fluorapatite
(Ca10(PO4)6F2) has a similar biocompatibility with HA in
terms of its fixation to bone and bone in-growth [6–8]. Qu
and Wei [10] studied discs doped with various amounts of
fluoride ion (F-) to investigate the effect of F- content on
osteoblastic cell behaviour. They concluded that FHA is
biocompatible and that the amount of F- affects cell
attachment, proliferation, morphology and differentiation
of osteoblastic cells. The first study to suggest that fluor-
apatite may have superior biological properties to HA was
Kim et al. [5]. This current study takes this work further
and suggests that fluorapatite (Ca10(PO4)6F2) and highly
substituted fluorhydroxyapatites (Ca10(PO4)6F1.5OH0.5)
possibly have a superior biocompatibility to HA.
These fluoride substituted apatites produced by the sol–
gel method in this study, have the potential to offer
themselves as highly biocompatible titanium implant
coating materials. Furthermore because of their high bio-
compatibility they could offer the potential as an alloplastic
bone grafting material. Currently clinically one of the most
commonly used bone grafting materials is BioOssTM
(Geistlich, Austria) which is made from deproteinised
bovine bone. It may be possible to produce a highly bio-
compatible osteoconductive material made from fluorapa-
tite/fluoride substituted hydroxyapatite that could be used
as a bone grafting material. The materials could be made in
blocks or differing particle sizes and offer a range of
properties depending on the level of fluoride substitution.
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5 Conclusions
(1) Increasing levels of fluoride substitution into an
apatite structure results in a structure that exhibits
slower dissolution compared to that with lower or no
fluoride substitution.
(2) Increased firing temperature up to 1000 C of
hydroxyapatite and fluoride substituted hydroxyapa-
tite results in a structure that exhibits slower disso-
lution compared to that with lower or no fluoride
substitution.
(3) Increasing the levels of fluoride substitution into an
apatite structure results in increased biocompatibility.
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